PDF
Kurs
+18,49%
Likviditet
35,4 MNOK
Kalender
| Tid* | ||
| 2025-11-06 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-14 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-27 | N/A | Årsstämma |
| 2025-05-08 | 07:00 | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | 16:30 | Bokslutskommuniké 2024 |
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-22 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-26 | - | Årsstämma |
| 2024-06-06 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-01 | - | Bokslutskommuniké 2023 |
| 2023-11-02 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-07 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2023-06-06 | - | Årsstämma |
| 2023-05-04 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-02 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-23 | - | Årsstämma |
| 2022-05-27 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-01-27 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-19 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-21 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2021-05-20 | - | Årsstämma |
| 2021-04-22 | - | Kvartalsrapport 2021-Q1 |
| 2021-01-28 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-19 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-15 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2020-05-14 | - | Årsstämma |
| 2020-04-23 | - | Kvartalsrapport 2020-Q1 |
| 2020-01-30 | - | Bokslutskommuniké 2019 |
| 2020-01-06 | - | Extra Bolagsstämma 2020 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-15 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-16 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2019-05-15 | - | Årsstämma |
| 2019-04-30 | - | Kvartalsrapport 2019-Q1 |
| 2019-01-30 | - | Bokslutskommuniké 2018 |
| 2018-10-18 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-09 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2018-05-07 | - | Årsstämma |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-01 | - | Bokslutskommuniké 2017 |
| 2017-10-19 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-17 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-12 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2017-05-11 | - | Årsstämma |
| 2017-04-27 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-02 | - | Bokslutskommuniké 2016 |
| 2016-10-26 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-12 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2016-05-11 | - | Årsstämma |
| 2016-04-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-11 | - | Kapitalmarknadsdag 2016 |
| 2016-02-11 | - | Bokslutskommuniké 2015 |
| 2015-11-03 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-13 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-13 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2015-05-12 | - | Årsstämma |
| 2015-05-05 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-17 | - | Bokslutskommuniké 2014 |
| 2014-11-05 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-13 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-15 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2014-05-14 | - | Årsstämma |
| 2014-04-30 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-14 | - | Bokslutskommuniké 2013 |
| 2013-11-01 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-09 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-13 | - | Kapitalmarknadsdag 2013 |
| 2013-05-28 | - | X-dag ordinarie utdelning |
| 2013-05-27 | - | Årsstämma |
| 2013-05-07 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-01 | - | Extra Bolagsstämma 2013 |
| 2013-01-07 | - | Bokslutskommuniké 2012 |
| 2012-11-06 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-10 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-07 | - | Årsstämma |
| 2012-05-07 | - | Kvartalsrapport 2012-Q1 |
| 2012-05-07 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2012-02-21 | - | Bokslutskommuniké 2011 |
| 2011-11-08 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-10 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-13 | - | Årsstämma |
| 2011-05-13 | - | Kvartalsrapport 2011-Q1 |
| 2011-05-12 | - | X-dag ordinarie utdelning |
| 2011-02-17 | - | Bokslutskommuniké 2010 |
| 2010-11-12 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-10 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-11 | - | Kvartalsrapport 2010-Q1 |
| 2010-05-04 | - | Årsstämma |
| 2010-03-03 | - | Bokslutskommuniké 2009 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Tromsø, Norway, 28[th] April 2022 - ArcticZymes Technologies (OSE: AZT) reported sales of NOK 49.2 million (40.9) and an EBITDA of NOK 27.9 million (25.8) for the first quarter of 2022.
- ArcticZymes Technologies (AZT) had Q1 sales of NOK 49.2 million growing by 21% (Q1 2021: NOK 40.9 million)
- Positive EBITDA of NOK 27.9 million (Q1 2021: NOK 25.8 million)
- Cash flow for Q1 was positive NOK 14.2 million (Q1 2021: NOK 23.2 million) giving a cash balance of NOK 214.6 million (Q1 2021: NOK 163.3 million)
- Signed a new OEM supply deal with a leading global Life Science company
- Established new application laboratory at ShareLab in Oslo
CEO Jethro Holter comments:
"We are delighted with the strong performance of our first quarter for 2022. The ArcticZymes team has delivered the best-ever quarterly performance achieving sales revenues of NOK 49.2 million and an EBITDA of NOK 27.9 million. Both Molecular Tools and Biomanufacturing were instrumental in delivering growth.
Furthermore, ArcticZymes is proud to expand its operational activities outside of Tromsø and strategically establish itself at ShareLab in Oslo. Initial activities at Sharelab will focus on application development."
-Ends-
First Quarter 2022 Presentation and Webcast
The Company will host a presentation for investors, analysts and media at 08:30 CET on Thursday, 28[th] April 2022 at Hotel Continental, Stortingsgata 24/26, Oslo.
The presentation will be given by CEO, Jethro Holter and CFO, Børge Sørvoll
The presentation can also be followed as a live webcast from Hegnar TV on www.arcticzymes.com or https://channel.royalcast.com/landingpage/hegnarmedia/20220428_14/. It will be possible to post questions through the webcast console.
The results, report and presentation for the first quarter 2022 will be available on www.newsweb.no (https://protect-eu.mimecast.com/s/ax_EC4xJkS8gx1SMlEBY?domain=newsweb.no) and on the Company's homepage www.arcticzymes.com from 07:00 CET on 28[th] April 2022.
For more information, please contact:
ArcticZymes Technologies ASA
CEO, Jethro Holter Tel: +47 46 85 91 46
CFO, Børge Sørvoll Tel: +47 95 29 01 87
ir@arcticzymes.com
About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and therapeutics.
Listed on the Oslo Stock Exchange since 2005 originally under the [Biotec] ticker, as Biotec Pharmacon. The company rebranded as ArcticZymes Technologies in 2020 under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA Innovation Centre.
ArcticZymes Technologies' IP and capabilities are protected via a large portfolio of patents.
For more information, please visit the website: www.arcticzymes.com